Alphabet Inc. - Q4 2019 holdings

$1.65 Billion is the total value of Alphabet Inc.'s 27 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 16.7% .

 Value Shares↓ Weighting
LYFT  Lyft Inc$551,902,000
+5.3%
12,828,9640.0%33.38%
+112.0%
JD  JD com Incspon adr cl a$477,489,000
+24.9%
13,553,4740.0%28.88%
+151.4%
DXCM BuyDexcom Inc$176,235,000
+969.1%
805,681
+629.4%
10.66%
+2052.9%
UBER SellUber Technologies Inc$112,454,000
-94.8%
3,781,241
-94.7%
6.80%
-89.6%
RCUS  Arcus Biosciences Inc$51,003,000
+11.0%
5,049,7860.0%3.08%
+123.3%
MGTA  Magenta Therapeutics Inc$50,621,000
+47.8%
3,339,1380.0%3.06%
+197.5%
FTSV SellForty Seven Inc$40,576,000
+308.8%
1,030,644
-33.3%
2.45%
+723.5%
WORK  Slack Technologies Inc.$29,219,000
-5.3%
1,299,7710.0%1.77%
+90.6%
NET  Cloudflare Inc$27,851,000
-8.1%
1,632,5190.0%1.68%
+84.9%
RAPT NewRAPT Therapeutics Inc$23,084,000836,059
+100.0%
1.40%
VIR NewVir Biotechnology Inc$20,958,0001,666,666
+100.0%
1.27%
FULC  Fulcrum Therapeutics Inc$11,886,000
+150.6%
714,2850.0%0.72%
+406.3%
SPRO  Spero Therapeutics Inc$10,696,000
-9.3%
1,112,4730.0%0.65%
+82.8%
CRTX SellCortexyme Inc$10,617,000
+36.4%
189,122
-39.4%
0.64%
+174.4%
AUTL  Autolus Therapeutics PLCspon ads$9,231,000
+6.3%
699,3520.0%0.56%
+113.8%
SNAP  Snap Inccl a$8,552,000
+3.3%
523,7100.0%0.52%
+107.6%
CRWD BuyCrowdstrike Hldgs Inccl a$8,529,000
+4.5%
171,020
+22.2%
0.52%
+110.6%
GRTS  Gritstone Oncology Inc$8,333,000
+3.9%
929,0220.0%0.50%
+109.1%
MWK  Mohawk Group Hldgs Inc$6,220,000
-24.7%
1,055,9540.0%0.38%
+51.6%
IDYA  Ideaya Biosciences Inc$5,649,000
-16.7%
753,1870.0%0.34%
+67.6%
CLDR  Cloudera Inc$4,974,000
+31.2%
427,7100.0%0.30%
+164.0%
EVLO  Evelo Biosciences Inc$4,306,000
-33.4%
1,060,4950.0%0.26%
+34.0%
ALEC SellAlector Inc$3,030,000
+6.4%
175,866
-10.9%
0.18%
+112.8%
DBX  Dropbox Inccl a$233,000
-11.4%
13,0330.0%0.01%
+75.0%
SPGI ExitS&P Global Inc$0-1,297
-100.0%
-0.01%
SQ ExitSquare Inccl a$0-12,342
-100.0%
-0.02%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPERO THERAPEUTICS INC24Q3 20233.5%
AUTOLUS THERAPEUTICS PLC22Q3 20232.8%
Magenta Therapeutics Inc.21Q2 20233.8%
DEXCOM INC20Q3 202317.4%
Evelo Biosciences Inc.20Q1 20231.6%
ALECTOR INC19Q3 20231.1%
Lyft Inc18Q2 202351.9%
QUINCE THERAPEUTICS INC18Q3 20230.6%
Arcus Biosciences Inc17Q1 202212.7%
FULCRUM THERAPEUTICS INC17Q3 20230.7%

View Alphabet Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Alphabet Inc. Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ARRIS International plcFebruary 14, 20197,603,5004.4%

View Alphabet Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
10-Q2024-04-26
1442024-04-26
42024-04-26
42024-04-26
ARS2024-04-26
DEF 14A2024-04-26
DEFA14A2024-04-26
8-K2024-04-25
1442024-04-17
1442024-04-17

View Alphabet Inc.'s complete filings history.

Compare quarters

Export Alphabet Inc.'s holdings